| Oct 27 |
Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024
|
| Oct 25 |
Key Biogen Tecfidera patent upheld by European Patent Office
|
| Oct 25 |
Arcutis Biotherapeutics, Inc. (ARQT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
|
| Oct 24 |
Will New Drugs Help Biogen Surpass Q3 Earnings Estimates?
|
| Oct 24 |
Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference
|
| Oct 24 |
The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron and Biogen
|
| Oct 23 |
Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
|
| Oct 23 |
The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and Biogen
|
| Oct 22 |
Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024
|
| Oct 20 |
Biogen Inc. (BIIB): An Oversold Large Cap Stock To Buy Now
|
